Piyasa Haberleri

En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis

Eli Lilly Q2: Strong Results Further Strengthen The Investment Thesis

Eli Lilly remains a buy after Q2, with robust revenue growth and strong performance from Mounjaro and Zepbound. LLY raised 2026 revenue guidance to $85–87 billion, driven by volume gains despite price declines, and reinforced margin expansion. Retatrutide is a key medium-term catalyst, with a BLA submission planned for Q1 2027 and potential in new therapeutic areas.

İlgili Semboller 1
LLY LLY
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Accesswire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Valeura Energy Inc. Announces Record Operational and Financial Performance in Q2 2026

Valeura Energy Inc. Announces Record Operational and Financial Performance in Q2 2026

CALGARY, AB / ACCESS Newswire / August 6, 2026 / Valeura Energy Inc. (TSX:VLE)(OTCQX:VLERF) ("Valeura" or the "Company") reports its unaudited financial and operating results for the three and six month periods ended 30 June 2026. The complete quarterly reporting package for the Company, including the unaudited financial statements (the "Interim Financial Statement") and associated management's discussion and analysis ("MD&A") are being filed on SEDAR+ at www.sedarplus.caand posted the Company's website at www.valeuraenergy.com.

İlgili Semboller 1
VLE VLE
Kaynak: Accesswire
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Reuters Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
OpenAI asks US judge to dismiss Apple's trade secrets case

OpenAI asks US judge to dismiss Apple's trade secrets case

OpenAI asked a U.S. judge on Wednesday to dismiss Apple's lawsuit ​accusing it and two former ‌Apple employees of misappropriating the iPhone maker's trade secrets to benefit the ChatGPT maker's ​foray into consumer hardware.

İlgili Semboller 1
AAPL Apple Inc.
Kaynak: Reuters
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: PRNewsWire Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

Collaboration combines Odyssey's disease biology expertise with Evotec's AI-enabled discovery platform, advanced screening capabilities and proprietary compound libraries to support advancement of Odyssey's discovery-stage programs Evotec to deliver validated hit series across multiple high-value targets for large inflammatory and autoimmune diseases with high unmet medical need HAMBURG, Germany, Aug. 6, 2026 /PRNewswire/ -- Evotec SE (NASDAQ: EVO) (Frankfurt Prime Standard: EVT) today announced that it has entered a strategic R&D collaboration with Odyssey Therapeutics, Inc. (NASDAQ: ODTX) to discover potential new treatments in autoimmune and inflammatory diseases. Under the agreement, Odyssey will leverage Evotec's integrated data-driven discovery platform, advanced screening capabilities and AI-enabled data science technologies to discover and validate differentiated small molecule drug candidates across multiple high-value disease targets.

İlgili Semboller 1
EVO EVO
Kaynak: PRNewsWire
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Proactive Investors Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Diversified Energy turns driller in shift away from acquisition-led growth

Diversified Energy turns driller in shift away from acquisition-led growth

Diversified Energy Company PLC (LSE:DEC, NYSE:DEC, FRA:DG20), the Alabama-based gas producer listed in London and New York, is to start drilling its own wells, a departure from the acquisition-led model that built the company. The company said it would launch a one-rig operated development programme in Oklahoma in the second half of this year, spending $35 million to $50 million.

İlgili Semboller 1
DEC DEC
Kaynak: Proactive Investors
Kaynağı Ziyaret Et
Official Partner ITBFX Start Trading
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Amkor Technology's Valuation Lags Its Growth

Amkor Technology's Valuation Lags Its Growth

Amkor Technology is rated Strong Buy, with record Q2 2026 performance and robust multi-year growth drivers from AI and advanced packaging. Q2 revenue surged 26% YoY to $1.90B, gross margin improved to 16.8%, and utilization rates reached the high 70s, with several lines at full capacity. Long-term contracts with TSMC and NVIDIA enhance planning visibility, support advanced packaging growth, and underpin confidence in future capacity loading.

İlgili Semboller 1
AMKR AMKR
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap
Kaynak: Seeking Alpha Haber Ajansı
1 ay önce
Hisse Senedi Orta Önem
Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences: It's Only Getting Worse

Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 revenues down, below consensus. Operating and net losses remain sizable, with cash now under $237 million and nearly $645 million in debt outstanding. PACB trades at 2.4x expected 2026 revenues, a steep discount to peers, reflecting weaker financials and growth prospects.

İlgili Semboller 1
PACB PACB
Kaynak: Seeking Alpha
Kaynağı Ziyaret Et
0 0 0
Devamını Oku
Yorum Yap